SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050527
Filing Date
2020-11-04
Accepted
2020-11-04 16:34:56
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q harp-10q_20200930.htm 10-Q 2849276
2 EX-31.1 harp-ex311_7.htm EX-31.1 17651
3 EX-31.2 harp-ex312_9.htm EX-31.2 17608
4 EX-32.1 harp-ex321_8.htm EX-32.1 8306
  Complete submission text file 0001564590-20-050527.txt   8954749

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT harp-20200930.xml EX-101.INS 2097816
6 XBRL TAXONOMY EXTENSION SCHEMA harp-20200930.xsd EX-101.SCH 48619
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20200930_cal.xml EX-101.CAL 43231
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20200930_def.xml EX-101.DEF 167395
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20200930_lab.xml EX-101.LAB 383361
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20200930_pre.xml EX-101.PRE 290360
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 201287192
SIC: 2836 Biological Products, (No Diagnostic Substances)